WHY I'M RUNNING
ALS is a progressive neurodegenerative disease of the nerve cells in the brain and spinal cord that control voluntary muscle movement. The popular Ice Bucket Challenge brought much national attention to the disease, but it wasn’t until I learned about the experience of the Bossman and Auger families that helped me deeply understand the disease’s true effects and consequences first-hand.
As a result, they have inspired me to be more of an emotional stakeholder by joining the national conversation about ALS from a different approach. That’s why this year, I’m looking to run the 2017 Falmouth Road Race in partnership with Compassionate Care ALS and in memory of both Robert Bossman and Dick Auger.
However, my run for Robert and Dick can’t happen without your support.
HOW CAN YOU HELP?
I’m looking to raise $1,500 for the Falmouth Road Race and CCALS in order to be eligible to participate on the day of the race. You can participate by donating to CCALS through my fundraising page here. Donations of any and all sizes are greatly appreciated.
The funds raised from your support help CCALS to continue to provide direct services and durable goods to ALS patients, their families, and their caregivers — and ultimately, keeping the conversation going towards finding treatments, care and finally, a cure. Your support also helps me get one step closer to honoring both Robert Bossman and Dick Auger's memory through my run in the race.
Please don't hesitate to contact me if you have any questions — firstname.lastname@example.org (e-mail) or 978-340-2790 (phone).
Thank you in advance for your support!
ABOUT COMPASSIONATE CARE ALS
Compassionate Care ALS is a non-profit organization with a mission to support people diagnosed with ALS, their families and communities as they navigate the complexities, both physical and emotional, associated with the disease. The organization provides resources including equipment, educational workshops, Medicare/Medicaid assistance, guidance and awareness in living with ALS, caregiving, and end-of-life issues.